Finally, data from mice indicates that human E4 expression increases LC tau pathology and cytosolic content of toxic NE metabolites via E4 disruption of vesicular monoamine transporter 2 (VMAT2) function74, indicating a direct mechanism for E4-mediated LC susceptibility to AD. Here, SLC18A2 is linked to Alzheimer disease.